Singapore markets close in 2 hours 45 minutes
Straits Times Index
3,283.19 -4.56 (-0.14%) Nikkei
37,927.86 +299.38 (+0.80%) Hang Seng
17,711.22 +426.68 (+2.47%) FTSE 100
8,078.86 +38.48 (+0.48%) Bitcoin USD
64,477.50 +179.21 (+0.28%) CMC Crypto 200
1,392.81 -3.73 (-0.27%)
Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 704.29M |
| Enterprise value | 451.41M |
| Trailing P/E | N/A |
| Forward P/E | 121.95 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.97 |
| Price/book (mrq) | 1.86 |
| Enterprise value/revenue | 2.57 |
| Enterprise value/EBITDA | -7.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.38 |
| 52-week change 3 | -56.71% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 12.4300 |
| 52-week low 3 | 4.7100 |
| 50-day moving average 3 | 5.3498 |
| 200-day moving average 3 | 7.9106 |
Share statistics
| Avg vol (3-month) 3 | 2.09M |
| Avg vol (10-day) 3 | 1.31M |
| Shares outstanding 5 | 144.62M |
| Implied shares outstanding 6 | 144.62M |
| Float 8 | 131.74M |
| % held by insiders 1 | 7.45% |
| % held by institutions 1 | 38.53% |
| Shares short (15 Apr 2024) 4 | 11.39M |
| Short ratio (15 Apr 2024) 4 | 8.02 |
| Short % of float (15 Apr 2024) 4 | 7.90% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.88% |
| Shares short (prior month 15 Mar 2024) 4 | 10.65M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -44.45% |
| Operating margin (ttm) | -52.72% |
Management effectiveness
| Return on assets (ttm) | -10.52% |
| Return on equity (ttm) | -19.92% |
Income statement
| Revenue (ttm) | 175.51M |
| Revenue per share (ttm) | 1.23 |
| Quarterly revenue growth (yoy) | 58.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -74.14M |
| Net income avi to common (ttm) | -78.02M |
| Diluted EPS (ttm) | -0.5400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 350.37M |
| Total cash per share (mrq) | 2.42 |
| Total debt (mrq) | 97.61M |
| Total debt/equity (mrq) | 25.82% |
| Current ratio (mrq) | 5.50 |
| Book value per share (mrq) | 2.63 |
Cash flow statement
| Operating cash flow (ttm) | -33.46M |
| Levered free cash flow (ttm) | -3.89M |
© 2024 Yahoo. All rights reserved.